BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15627815)

  • 21. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.
    Sättler MB; Merkler D; Maier K; Stadelmann C; Ehrenreich H; Bähr M; Diem R
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S181-92. PubMed ID: 15459752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.
    Digicaylioglu M; Lipton SA
    Nature; 2001 Aug; 412(6847):641-7. PubMed ID: 11493922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythropoietin and neuroprotection].
    Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
    Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin in neonatal brain protection: the past, the present and the future.
    Kumral A; Tüzün F; Oner MG; Genç S; Duman N; Ozkan H
    Brain Dev; 2011 Sep; 33(8):632-43. PubMed ID: 21109375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertion of an NPVY sequence into the cytosolic domain of the erythropoietin receptor selectively affects erythropoietin-mediated signalling and function.
    Liron T; Nahari T; Souroujon MC; Neumann D
    Biochem J; 2010 Mar; 427(2):305-12. PubMed ID: 20136632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades.
    Chong ZZ; Kang JQ; Maiese K
    J Cereb Blood Flow Metab; 2002 May; 22(5):503-14. PubMed ID: 11973422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New avenues of exploration for erythropoietin.
    Maiese K; Li F; Chong ZZ
    JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
    Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
    J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of erythropoietin and angiogenic growth factors following inner ear injury of newborn rats.
    Gross J; Moller R; Amarjargal N; Machulik A; Fuchs J; Ungethüm U; Kuban RJ; Henke W; Haupt H; Mazurek B
    Prague Med Rep; 2009; 110(4):310-31. PubMed ID: 20059883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL/6 mouse brain.
    Kumral A; Tugyan K; Gonenc S; Genc K; Genc S; Sonmez U; Yilmaz O; Duman N; Uysal N; Ozkan H
    Brain Res Dev Brain Res; 2005 Dec; 160(2):146-56. PubMed ID: 16236368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T; Nangaku M
    Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective role of erythropoietin in neonates.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling.
    Chong ZZ; Shang YC; Maiese K
    Curr Neurovasc Res; 2007 Aug; 4(3):194-204. PubMed ID: 17691973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
    Maiese K; Chong ZZ; Li F; Shang YC
    Prog Neurobiol; 2008 Jun; 85(2):194-213. PubMed ID: 18396368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preconditioning-mediated neuroprotection through erythropoietin?
    Dawson TM
    Lancet; 2002 Jan; 359(9301):96-7. PubMed ID: 11809248
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress on neuroprotective effects of erythropoietin].
    Liu X; Wu H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 42(6):693-9. PubMed ID: 24421239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
    Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
    Hasselblatt M; Ehrenreich H; Sirén AL
    J Neurosurg Anesthesiol; 2006 Apr; 18(2):132-8. PubMed ID: 16628067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.